Clinical Trial

Adaptive Interventions for Emergency Department Patients With Opioid Use Disorder

Study acronym: ADAPT-ED
Recruiting
View on ClinicalTrials.gov →
Summary
The ADAPT-ED study is a two-stage, sequential multiple assignment randomized trial (SMART) to inform the development of an adaptive intervention that is optimally effective in increasing long-term buprenorphine use for adults presenting to the ED with probable opioid use disorder (OUD).
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-02-10; most recent amendment 2026-02-17.
Status change: Enrolling by Invitation → Recruiting 2025-03-20
Status change: Recruiting → Enrolling by Invitation 2025-03-14
Trial Details
NCT Number NCT06827288
Lead Sponsor RAND
Collaborators: Arrowhead Regional Medical Center, Alameda Health System, Stanford University
Conditions Opioid Use Disorder
Enrollment 500 participants
Start Date 2024-10-04
Primary Completion 2027-06-30 (estimated)
Study Completion 2028-03-31 (estimated)
Updated on ClinicalTrials.gov 2026-02-19